PRODUCT DISTRIBUTION ISSUE

This adverse event was reported 9285 times

These drugs are most commonly taken by patients reporting PRODUCT DISTRIBUTION ISSUE:

# Drug Count
0 LENALIDOMIDE 1247
1 CERTOLIZUMAB PEGOL 471
2 ERGOCALCIFEROL 398
3 ACETAMINOPHEN 397
4 POMALIDOMIDE 378
5 SECUKINUMAB 370
6 RUXOLITINIB 366
7 ASPIRIN 319
8 ASPIRIN 325 MG 312
9 ASPIRIN 81 MG 312
See all common drugs associated with PRODUCT DISTRIBUTION ISSUE

PRODUCT DISTRIBUTION ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 118 0.0342
1 BRODALUMAB 55 0.0267
2 ROPEGINTERFERON ALFA-2B 36 0.0194
3 MITAPIVAT 25 0.0188
4 MARIBAVIR 43 0.0174
5 LANADELUMAB-FLYO 49 0.0152
6 ETEPLIRSEN 35 0.0145
7 HUMAN IMMUNOGLOBULIN G 294 0.0140
8 ERGOCALCIFEROL 398 0.0134
9 VELAGLUCERASE ALFA 26 0.0127
See all drugs enriched for association with PRODUCT DISTRIBUTION ISSUE